| Recent trends in protein and peptide-based biomaterials for advanced drug delivery A Varanko, S Saha, (co-first author), A Chilkoti Advanced Drug Delivery Reviews, 2020 | 228 | 2020 |
| Simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes of pegylated RGDK-lipopeptide to tumor vasculature S Barui, S Saha, (co-first author), G Mondal, S Haseena, A Chaudhuri Biomaterials 35 (5), 1643-1656, 2014 | 142 | 2014 |
| Engineering the Architecture of Elastin‐Like Polypeptides: From Unimers to Hierarchical Self‐Assembly S Saha, S Banskota, S Roberts, N Kirmani, A Chilkoti Advanced Therapeutics, 2020 | 67 | 2020 |
| Tumor growth inhibition through targeting liposomally bound curcumin to tumor vasculature G Mondal, S Barui, S Saha, A Chaudhuri Journal of Controlled Release 172 (3), 832-840, 2013 | 54 | 2013 |
| Conjugate of Doxorubicin to Albumin‐Binding Peptide Outperforms Aldoxorubicin P Yousefpour, L Ahn, J Tewksbury, S Saha, SA Costa, JJ Bellucci, X Li, ... Small 15 (12), 1804452, 2019 | 53 | 2019 |
| Genetically encoded stealth nanoparticles of a Zwitterionic polypeptide-paclitaxel conjugate have a wider therapeutic window than Abraxane in multiple tumor models S Banskota, S Saha, J Bhattacharya, N Kirmani, P Yousefpour, ... Nano letters 20 (4), 2396-2409, 2020 | 43 | 2020 |
| Amphetamine decorated cationic lipid nanoparticles cross the blood–brain barrier: Therapeutic promise for combating glioblastoma S Saha, V Yakati, G Shankar, MMCS Jaggarapu, G Moku, ... Journal of Materials Chemistry B 8 (19), 4318-4330, 2020 | 42 | 2020 |
| A nanoparticle’s journey to the tumor: strategies to overcome first-pass metabolism and their limitations JJ Milligan, S Saha Cancers 14 (7), 1741, 2022 | 38 | 2022 |
| Genetically encoded elastin-like polypeptide nanoparticles for drug delivery JJ Milligan, S Saha, IC Jenkins, A Chilkoti Current Opinion in Biotechnology 74, 146-153, 2022 | 29 | 2022 |
| Systemic codelivery of a homoserine derived ceramide analogue and curcumin to tumor vasculature inhibits mouse tumor growth S Barui, S Saha, (co-first author), V Yakati, A Chaudhuri Molecular pharmaceutics 13 (2), 404-419, 2016 | 23 | 2016 |
| Combating Established Mouse Glioblastoma through Nicotinylated‐Liposomes‐Mediated Targeted Chemotherapy in Combination with Dendritic‐Cell‐Based Genetic Immunization S Saha, Y Venu, D Bhattacharya, SD Kompella, K Madhusudana, ... Advanced Biosystems 1 (1-2), 1600009, 2017 | 17 | 2017 |
| Brachytherapy via a depot of biopolymer-bound 131I synergizes with nanoparticle paclitaxel in therapy-resistant pancreatic tumours JL Schaal, J Bhattacharyya, J Brownstein, KC Strickland, G Kelly, S Saha, ... Nature biomedical engineering 6 (10), 1148-1166, 2022 | 15 | 2022 |
| Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in Pten-deleted Mouse Models of Sarcoma RD Dodd, A Scherer, W Huang, GR McGivney, WR Gutierrez, EA Laverty, ... Clinical Cancer Research 26 (18), 5036-5047, 2020 | 9 | 2020 |
| Heuristics for the optimal presentation of bioactive peptides on polypeptide micelles J Wang, S Saha, JL Schaal, P Yousefpour, X Li, A Chilkoti Nano Letters 19 (11), 7977-7987, 2019 | 7 | 2019 |
| Genetically engineered nanoparticles of asymmetric triblock polypeptide with a platinum (IV) cargo outperforms a platinum (II) analog and free drug in a murine cancer model S Saha, S Banskota, J Liu, N Zakharov, M Dzuricky, X Li, P Fan, ... Nano letters 22 (14), 5898-5908, 2022 | 5 | 2022 |
| In vivo targeting of tumor-antigen encoded DNA vaccine to dendritic cells in combination with tumor-selective chemotherapy eradicates established mouse melanoma S Barui, S Saha (co-first author), V Yakati, GK Moku, A Chaudhuri Biomaterials Science, 2023 | 2 | 2023 |
| Novel Suberoylanilide Hydroxamic Acid Analogs Inhibit Angiogenesis and Induce Apoptosis in Breast Cancer Cells G Moku, S Vangala, V Yakati, CC Gali, S Saha, VS Madamsetty, A Vyas Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2022 | 1 | 2022 |
| 131I-ELP brachytherapy synergizes with nanoparticle paclitaxel to overcome resistance to radio-chemotherapy in multiple pancreatic tumors JL Schaal, J Bhattacharyya, J Brownstein, KC Strickland, G Kelly, S Saha, ... Nature biomedical engineering 6 (10), 1148, 2022 | | 2022 |
| Cationic lipid formulations for regressing established tumor S Barui, S Saha, C Arabinda US Patent 9,944,676, 2018 | | 2018 |
Ashutosh ChilkotiDuke University在 duke.edu 的电子邮件经过验证
